Hepaglide Price in India: Availability, Cost, and How to Get It
A practical May 2026 guide to Hepaglide prices in India, including launch pricing, current Tata 1mg listings, dose-wise costs, and prescription access.

Hepaglide Price in India: Availability, Cost, and How to Get It
Hepaglide is one of Alkem’s semaglutide brands in India, and it entered the market at a much lower starting price than older originator brands. If you are comparing GLP-1 options for weight management or type 2 diabetes, the useful question is not just “What is Hepaglide?” but also how much does it actually cost at different doses, and where can you realistically find it?
This guide gives you a practical snapshot as of May 8, 2026. Prices can still vary by pharmacy, city, discounts, and stock status, but the broad pricing band is much clearer now than it was at launch. Consult your healthcare provider before starting any medication.
What is Hepaglide?
Hepaglide is a semaglutide brand from Alkem Laboratories. It belongs to the GLP-1 receptor agonist class and is given as a once-weekly injection.
Alkem launched semaglutide in India on March 21, 2026 under three brand names:
- Semasize
- Obesema
- Hepaglide
According to Alkem’s launch announcement, the product is approved in India for:
- type 2 diabetes mellitus
- chronic weight management
The company also said it offers both:
- a pre-filled disposable injection pen for starting doses
- a reusable injection pen for higher maintenance dosing
Hepaglide price in India: current range
Alkem said at launch that its semaglutide injection would start at ₹450 per week, or ₹1,800 for a month’s dosage in the pre-filled disposable pen format.
Current Tata 1mg listings reviewed on May 8, 2026 are broadly consistent with that positioning. Examples include:
| Hepaglide dose | Approx. Tata 1mg listed price* |
|---|---|
| 0.25 mg | ₹1,625 |
| 0.5 mg | ₹1,716 |
| 1 mg | ₹1,806 |
| 1.7 mg | ₹2,258 |
| 2.4 mg | ₹3,161 |
*These are online listed prices and may reflect discounts versus MRP. Final checkout price and availability can change.
What this means in practical terms
At lower doses, Hepaglide sits in the ₹1,600 to ₹1,800 per month range on Tata 1mg. As doses rise, monthly cost climbs, with the 2.4 mg strength crossing ₹3,000.
That still places Hepaglide well below older semaglutide price points such as originator-brand Ozempic in India, but the exact affordability depends on where you are in dose escalation.
Is Hepaglide available in India now?
Yes — Hepaglide is available in India, but real-world access still depends on:
- your city
- the pharmacy you use
- whether the dose you need is in stock
- whether you are buying through an offline chemist or an online platform
Tata 1mg listings indicate that multiple Hepaglide strengths are already in circulation. At the same time, higher-dose products can still show limited stock or temporary unavailability, which is fairly common with newer GLP-1 launches.
So the best way to think about availability is: available, but not always equally available at every dose in every pharmacy.
How Hepaglide compares with Alkem’s launch pricing
Alkem’s official launch positioning was straightforward:
- starting weekly cost: ₹450
- starting monthly cost: ₹1,800
That launch pricing lines up closely with the lower-dose Tata 1mg listings now visible in the market. In other words, the pricing message from the launch was not just promotional language — current retail listings still roughly support it.
Why the price changes by dose
This is where many patients get confused. The lowest headline number is usually a starter-dose price, not the permanent monthly cost for everyone.
Your monthly cost may rise because:
- you begin at a lower initiation dose and later move higher
- higher strengths contain more semaglutide and cost more
- some pharmacies apply different discounts by SKU
- stock shortages can change what is actually purchasable at a given moment
So if you are budgeting for treatment, ask about the likely maintenance dose cost, not just the entry price.
Do you need a prescription to buy Hepaglide?
Yes. Hepaglide is a prescription medicine in India and should be used only under medical supervision.
That matters for several reasons:
- semaglutide is not appropriate for everyone
- dose escalation needs planning
- side effects such as nausea, vomiting, constipation, or diarrhea may need management
- people with diabetes may need broader treatment review, not just a stand-alone prescription
If a seller offers Hepaglide without a proper prescription process, that is a warning sign.
How to get Hepaglide in India
A simple safe route looks like this:
- Consult a qualified doctor about whether semaglutide is appropriate for your case
- Get the exact brand and dose written clearly on the prescription
- Check 2–3 licensed pharmacies or major online platforms for current stock and price
- Confirm storage conditions because semaglutide products require cold-chain handling
- Ask what your next likely dose will cost, not just the first pen
That last step saves a lot of surprises.
Is Hepaglide covered by insurance?
Insurance coverage in India is still inconsistent for GLP-1 medications.
If Hepaglide is prescribed for type 2 diabetes, coverage may be more plausible depending on your plan’s medicine benefits. If it is prescribed for weight management, coverage is often less predictable. Many plans still do not handle obesity medicines generously.
So the practical answer is: check your exact policy rather than assuming it is covered.
Bottom line
As of May 8, 2026, Hepaglide is a real lower-cost semaglutide option in India, not just a launch announcement. Alkem introduced it at ₹450 per week / ₹1,800 per month for starter dosing, and current Tata 1mg listings show a roughly ₹1,625 to ₹3,161 dose-dependent price range across available strengths.
That makes Hepaglide one of the more accessible semaglutide brands in India, especially at lower doses. But the number that matters most for patients is often the maintenance-dose monthly cost, not the headline entry price. Consult your healthcare provider before starting any medication.
Sources
- Alkem Laboratories launch announcement, March 21, 2026: https://admin.alkemlabs.com/uploads/Press_Release_Alkem_Semaglutide_Day_1_launch_final_fc1e90e3be.pdf
- Tata 1mg brand page for Hepaglide: https://www.1mg.com/brands/hepaglide-aGVwYWdsaWRl
- Tata 1mg Hepaglide 0.5 mg listing: https://www.1mg.com/drugs/hepaglide-0.5mg-injection-1-multi-dose-disposable-pen-4-needle-4-alcohol-swab-1149949
- Tata 1mg Hepaglide 1 mg listing: https://www.1mg.com/drugs/hepaglide-1mg-injection-1-multi-dose-disposable-pen-4-needle-4-alcohol-swab-1149951
- Tata 1mg Hepaglide 1.7 mg listing: https://www.1mg.com/drugs/hepaglide-1.7mg-injection-1-multi-dose-disposable-pen-4-needle-4-alcohol-swab-1149952
- Tata 1mg Hepaglide 2.4 mg listing: https://www.1mg.com/drugs/hepaglide-2.4mg-injection-1-multi-dose-disposable-pen-4-needle-4-alcohol-swab-1149953
Written by
B.com
Content Writer
Bikki Varma is a B.com professional who contributes evidence-informed health and wellness content for WeightEasy.
View profile →Reviewed by
Immunobiologist
Senior Medical Reviewer
Dr Kshama Jain is an Immunobiologist professional who reviews WeightEasy health content for medical and editorial accuracy.
View profile →